We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

160 hedge funds and large institutions have $2.25B invested in Axonics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 52 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 23

30% more capital invested

Capital invested by funds: $1.74B → $2.25B (+$513M)

7% more funds holding

Funds holding: 149160 (+11)

6% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 52

6% less call options, than puts

Call options by funds: $16M | Put options by funds: $17M

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
160
Holders Change
+11
Holders Change %
+7.38%
% of All Funds
2.81%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
36
Increased
55
Reduced
52
Closed
23
Calls
$16M
Puts
$17M
Net Calls
-$948K
Net Calls Change
+$3.28M
Name Holding Trade Value Shares
Change
Change in
Stake
DTL
176
Dynamic Technology Lab
Singapore
-$275K -5,518 Closed
WCM
177
Weld Capital Management
New York
-$205K -4,115 Closed
Man Group
178
Man Group
United Kingdom
-$203K -4,063 Closed
ECM
179
ExodusPoint Capital Management
New York
-$14K -290 Closed
CG
180
Cutler Group
California
-$14K -281 Closed
AL
181
ADE LLC
Maryland
-$12K -240 Closed
VAIA
182
Virtus Alternative Investment Advisers
Connecticut
-$6K -128 Closed
ASN
183
Advisory Services Network
Georgia
-$6K -119 Closed

AXNX Hedge Fund Activity: Q1 2021 in Review

160 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2021, worth a combined $2.25B — up 30% from $1.74B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new AXNX positions and 23 closed out — a net gain of 13 holders — while 55 added to existing stakes and 52 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $34.8M. The largest seller was Deerfield Management, exiting entirely with an estimated $39.9M sold.

  • 160 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2021, up from 149 in Q4 2020.
  • Funds reported $2.25B of Axonics, Inc. Common Stock stock for Q1 2021, up 30% quarter-over-quarter.
  • 36 funds opened new Axonics, Inc. Common Stock positions in Q1 2021 and 23 closed out, a net change of +13 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q1 2021 was Citadel Advisors, an estimated $34.8M added.
  • The largest Axonics, Inc. Common Stock seller in Q1 2021 was Deerfield Management, an estimated $39.9M sold.

Based on aggregated 13F filings for Q1 2021.